CNS Drugs Journal Issues Research Articles in February 2023 Edition
February 10, 2023
February 10, 2023
CHAM, Switzerland, Feb. 10 -- CNS Drugs, a journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles on the following topics in its February 2023 edition:
Leading Article:
* The Role of Gut Dysbiosis and Potential Approaches to Target the Gut Microbiota in Multiple Sclerosis
Systematic Review:
. . .
Leading Article:
* The Role of Gut Dysbiosis and Potential Approaches to Target the Gut Microbiota in Multiple Sclerosis
Systematic Review:
. . .